Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
September 6, 2018 425

Filing of certain prospectuses and communications in connection with business combination transactions

View HTML
August 31, 2018 SC 13G/A

An amendment to the SC 13G filing

View HTML
August 29, 2018 3

Initial filing by director officer or owner of more than ten percent.

View HTML
August 29, 2018 4

Statement of changes in beneficial ownership of securities

View HTML
August 28, 2018 8-K

Report of unscheduled material events or corporate event

View HTML
August 9, 2018 425

Filing of certain prospectuses and communications in connection with business combination transactions

View HTML
August 8, 2018 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
July 12, 2018 4

Statement of changes in beneficial ownership of securities

View HTML
July 11, 2018 425

Filing of certain prospectuses and communications in connection with business combination transactions

View HTML
July 3, 2018 SC 13D/A

An amendment to a SC 13D filing

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us